Skip to main content
SpringerLink
Log in

Miscellaneous: SPECT and SPECT/CT for Brain and Inflammation Imaging and Radiation Planning

  • Chapter
  • First Online:
Book cover Clinical Applications of SPECT-CT

  • 1636 Accesses

Abstract

Combination of SPECT (single-photon emission computed tomography) with CT (computed tomography) provides the opportunity for a direct correlation of anatomic information and functional data and leads to a better localization and definition of scintigraphic findings. Besides anatomic referencing, the other advantage of CT co-registration is the attenuation correction capabilities of CT. These advantages together result in a higher specificity of imaging and a significant reduction in indeterminate findings. This chapter highlights the potential clinical applications of integrated SPECT/CT in neurology, inflammation imaging, and radiation planning and summarizes future directions for SPECT/CT in these fields.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Charron M, del Rosario FJ, Kocoshis SA. Pediatric inflammatory bowel disease: assessment with scintigraphy with 99mTc white blood cells. Radiology. 1999;212:507–13.

    Article  PubMed  CAS  Google Scholar 

  2. Gotthardt M, Bleeker-Rovers CP, Boerman OC, Oyen WJG. Imaging of inflammation by PET, conventional scintigraphy, and other imaging techniques. J Nucl Med. 2010;51:1937–49.

    PubMed  Google Scholar 

  3. Horsthuis K, Bipat S, Bennink RJ, Stoker J. Inflammatory bowel disease diagnosed with US, MR, scintigraphy, and CT: meta-analysis of prospective studies. Radiology. 2008;247:64–79. doi:10.1148/radiol.2471070611.

    Article  PubMed  Google Scholar 

  4. Molnar T, Papos M, Gyulai C, Ambrus E, Kardos L, Nagy F, et al. Clinical value of technetium-99m-HMPAO-labeled leukocyte scintigraphy and spiral computed tomography in active Crohn’s disease. Am J Gastroenterol. 2001;96:1517–21. doi:10.1111/j.1572-0241.2001.03749.x.

    PubMed  CAS  Google Scholar 

  5. Rispo A, Imbriaco M, Celentano L, Cozzolino A, Camera L, Mainenti PP, et al. Noninvasive diagnosis of small bowel Crohn’s disease: combined use of bowel sonography and Tc-99m-HMPAO leukocyte scintigraphy. Inflamm Bowel Dis. 2005;11:376–82.

    Article  PubMed  Google Scholar 

  6. Spier BJ, Perlman SB, Reichelderfer M. FDG-PET in inflammatory bowel disease. Q J Nucl Med Mol Imaging. 2009;53:64–71.

    PubMed  CAS  Google Scholar 

  7. Stathaki MI, Koukouraki SI, Karkavitsas NS, Koutroubakis IE. Role of scintigraphy in inflammatory bowel disease. World J Gastroenterol. 2009;15:2693–700.

    Article  PubMed  CAS  Google Scholar 

  8. Rothstein RD. The role of scintigraphy in the management of inflammatory bowel disease. J Nucl Med. 1991;32:856–9.

    PubMed  CAS  Google Scholar 

  9. Koutroubakis IE, Koukouraki SI, Dimoulios PD, Velidaki AA, Karkavitsas NS, Kouroumalis EA. Active inflammatory bowel disease: evaluation with 99mTc (V) DMSA scintigraphy. Radiology. 2003;229:70–4.

    Article  PubMed  Google Scholar 

  10. Lee BF, Chiu NT, Wu DC, Tsai KB, Liu GC, Yu HS, et al. Use of 99mTc (V) DMSA scintigraphy in the detection and localization of intestinal inflammation: comparison of findings and colonoscopy and biopsy. Radiology. 2001;220:381–5.

    Article  PubMed  CAS  Google Scholar 

  11. Love C, Marwin SE, Palestro CJ. Nuclear medicine and the infected joint replacement. Semin Nucl Med. 2009;39:66–78.

    Article  PubMed  Google Scholar 

  12. Sans M, Fuster D, Llach J, Lomena F, Bordas JM, Herranz R, et al. Optimization of technetium-99m-HMPAO leukocyte scintigraphy in evaluation of active inflammatory bowel disease. Dig Dis Sci. 2000;45:1828–35.

    Article  PubMed  CAS  Google Scholar 

  13. Stathaki MI, Koutroubakis IE, Koukouraki SI, Karmiris KP, Moschandreas JA, Kouroumalis EA, et al. Active inflammatory bowel disease: head-to-head comparison between 99mTc-hexamethylpropylene amine oxime white blood cells and 99mTc(V)-dimercaptosuccinic acid scintigraphy. Nucl Med Commun. 2008;29:27–32.

    Article  PubMed  Google Scholar 

  14. Buchbender C, Ostendorf B, Mattes-Gyorgy K, Miese F, Wittsack H-J, Quentin M, et al. Synovitis and bone inflammation in early rheumatoid arthritis: high-resolution multi-pinhole SPECT versus MRI. Diagn Interv Radiol. 2013;19:20–4.

    PubMed  Google Scholar 

  15. Love C, Tomas MB, Marwin SE, Pugliese PV, Palestro CJ. Role of nuclear medicine in diagnosis of the infected joint replacement. Radiographics. 2001;21:1229–38.

    Article  PubMed  CAS  Google Scholar 

  16. Ostendorf B, Mattes-Gyorgy K, Reichelt DC, Blondin D, Wirrwar A, Lanzman R, et al. Early detection of bony alterations in rheumatoid and erosive arthritis of finger joints with high-resolution single photon emission computed tomography, and differentiation between them. Skeletal Radiol. 2010;39:55–61.

    Article  PubMed  CAS  Google Scholar 

  17. Roivainen A, Parkkola R, Yli-Kerttula T, Lehikoinen P, Viljanen T, Mottonen T, et al. Use of positron emission tomography with methyl-11C-choline and 2-18F-fluoro-2-deoxy-D-glucose in comparison with magnetic resonance imaging for the assessment of inflammatory proliferation of synovium. Arthritis Rheum. 2003;48:3077–84.

    Article  PubMed  CAS  Google Scholar 

  18. Segura AB, Munoz A, Brulles YR, Hernandez Hermoso JA, Diaz MC, Bajen Lazaro MT, et al. What is the role of bone scintigraphy in the diagnosis of infected joint prostheses? Nucl Med Commun. 2004;25:527–32.

    Article  PubMed  Google Scholar 

  19. Szkudlarek M, Narvestad E, Klarlund M, Court-Payen M, Thomsen HS, Ostergaard M. Ultrasonography of the metatarsophalangeal joints in rheumatoid arthritis: comparison with magnetic resonance imaging, conventional radiography, and clinical examination. Arthritis Rheum. 2004;50:2103–12.

    Article  PubMed  Google Scholar 

  20. Homonnai A, Kontz K, Tombacz A. The role of gallium scintigraphy in the diagnosis of sarcoidosis and in monitoring treatment effectiveness. Orv Hetil. 2006;147:1229–32.

    PubMed  Google Scholar 

  21. Jin S, Wang G, He B, Zhu M. Gallium-67 scanning for detection of alveolitis in idiopathic pulmonary fibrosis and sarcoidosis. Chin Med J (Engl). 1996;109:519–21.

    CAS  Google Scholar 

  22. Lebtahi R, Crestani B, Belmatoug N, Daou D, Genin R, Dombret MC, et al. Somatostatin receptor scintigraphy and gallium scintigraphy in patients with sarcoidosis. J Nucl Med. 2001;42:21–6.

    PubMed  CAS  Google Scholar 

  23. Okayama K, Kurata C, Tawarahara K, Wakabayashi Y, Chida K, Sato A. Diagnostic and prognostic value of myocardial scintigraphy with thallium-201 and gallium-67 in cardiac sarcoidosis. Chest. 1995;107:330–4.

    Article  PubMed  CAS  Google Scholar 

  24. Sy WM, Seo IS, Homs CJ, Gulrajani R, Sze P, Smith KF, et al. The evolutional stage changes in sarcoidosis on gallium-67 scintigraphy. Ann Nucl Med. 1998;12:77–82.

    Article  PubMed  CAS  Google Scholar 

  25. Tawarahara K, Kurata C, Okayama K, Kobayashi A, Yamazaki N. Thallium-201 and gallium 67 single photon emission computed tomographic imaging in cardiac sarcoidosis. Am Heart J. 1992;124:1383–4.

    Article  PubMed  CAS  Google Scholar 

  26. Xiu Y, Yu JQ, Cheng E, Kumar R, Alavi A, Zhuang H. Sarcoidosis demonstrated by FDG PET imaging with negative findings on gallium scintigraphy. Clin Nucl Med. 2005;30:193–5.

    Article  PubMed  Google Scholar 

  27. Palestro CJ, Schultz B, Horowitz M, Swyer AJ. Indium-111-leukocyte and gallium-67 imaging in acute sarcoidosis: report of two patients. J Nucl Med. 1992;33:2027–9.

    PubMed  CAS  Google Scholar 

  28. Alavi A, Palevsky HI. Gallium-67-citrate scanning in the assessment of disease activity in sarcoidosis. J Nucl Med. 1992;33:751–5.

    PubMed  CAS  Google Scholar 

  29. Israel HL, Albertine KH, Park CH, Patrick H. Whole-body gallium 67 scans. Role in diagnosis of sarcoidosis. Am Rev Respir Dis. 1991;144:1182–6.

    Article  PubMed  CAS  Google Scholar 

  30. Meller J, Altenvoerde G, Munzel U, Jauho A, Behe M, Gratz S, et al. Fever of unknown origin: prospective comparison of [18F]FDG imaging with a double-head coincidence camera and gallium-67 citrate SPET. Eur J Nucl Med. 2000;27:1617–25.

    Article  PubMed  CAS  Google Scholar 

  31. Meller J, Becker W. Nuclear medicine diagnosis of patients with fever of unknown origin (FUO). Nuklearmedizin. 2001;40:59–70.

    PubMed  CAS  Google Scholar 

  32. Meller J, Sahlmann CO, Gurocak O, Liersch T, Meller B. FDG-PET in patients with fever of unknown origin: the importance of diagnosing large vessel vasculitis. Q J Nucl Med Mol Imaging. 2009;53:51–63.

    PubMed  CAS  Google Scholar 

  33. Meller J, Sahlmann C-O, Scheel AK. 18F-FDG PET and PET/CT in fever of unknown origin. J Nucl Med. 2007;48:35–45.

    PubMed  CAS  Google Scholar 

  34. Myslivecek M, Husak V, Kolek V, Budikova M, Koranda P. Absolute quantitation of gallium-67 citrate accumulation in the lungs and its importance for the evaluation of disease activity in pulmonary sarcoidosis. Eur J Nucl Med. 1992;19:1016–22.

    Article  PubMed  CAS  Google Scholar 

  35. Depboylu C, Maurer L, Matusch A, Hermanns G, Windolph A, Behe M, et al. Effect of long-term treatment with pramipexole or levodopa on presynaptic markers assessed by longitudinal [(123)I]FP-CIT SPECT and histochemistry. Neuroimage. 2013;79:191–200.

    Article  PubMed  CAS  Google Scholar 

  36. Garibotto V, Montandon ML, Viaud CT, Allaoua M, Assal F, Burkhard PR, et al. Regions of interest-based discriminant analysis of DaTSCAN SPECT and FDG-PET for the classification of dementia. Clin Nucl Med. 2013;38:112–7.

    Article  Google Scholar 

  37. Ravina B, Marek K, Eberly S, Oakes D, Kurlan R, Ascherio A, et al. Dopamine transporter imaging is associated with long-term outcomes in Parkinson’s disease. Mov Disord. 2012;27:1392–7.

    Article  PubMed  Google Scholar 

  38. Eicker SO, Turowski B, Heiroth HJ, Steiger HJ, Hanggi D. A comparative study of perfusion CT and 99m Tc-HMPAO SPECT measurement to assess cerebrovascular reserve capacity in patients with internal carotid artery occlusion. Eur J Med Res. 2011;16:484–90.

    Article  PubMed  Google Scholar 

  39. Hirano T, Yonehara T, Inatomi Y, Hashimoto Y, Uchino M. Presence of early ischemic changes on computed tomography depends on severity and the duration of hypoperfusion: a single photon emission-computed tomographic study. Stroke. 2005;36:2601–8.

    Article  PubMed  Google Scholar 

  40. Krishnananthan R, Minoshima S, Lewis D. Tc-99m ECD neuro-SPECT and diffusion weighted MRI in the detection of the anatomical extent of subacute stroke: a cautionary note regarding reperfusion hyperemia. Clin Nucl Med. 2007;32:700–2.

    Article  PubMed  Google Scholar 

  41. Song H-C, Bom H-S, Cho KH, Kim BC, Seo J-J, Kim C-G, et al. Prognostication of recovery in patients with acute ischemic stroke through the use of brain SPECT with technetium-99m–labeled metronidazole. Stroke. 2003;34:982–6.

    Article  PubMed  Google Scholar 

  42. Uruma G, Kakuda W, Abo M. Changes in regional cerebral blood flow in the right cortex homologous to left language areas are directly affected by left hemispheric damage in aphasic stroke patients: evaluation by Tc-ECD SPECT and novel analytic software. Eur J Neurol. 2010;17:461–9.

    Article  PubMed  CAS  Google Scholar 

  43. Kim JH, Lee EJ, Lee SJ, Choi NC, Lim BH, Shin T. Comparative evaluation of cerebral blood volume and cerebral blood flow in acute ischemic stroke by using perfusion-weighted MR imaging and SPECT. Acta Radiol. 2002;43:365–70.

    Article  PubMed  CAS  Google Scholar 

  44. Ogasawara K, Ogawa A, Ezura M, Konno H, Doi M, Kuroda K, et al. Dynamic and static 99mTc-ECD SPECT imaging of subacute cerebral infarction: comparison with 133Xe SPECT. J Nucl Med. 2001;42:543–7.

    PubMed  CAS  Google Scholar 

  45. Ogasawara K, Ogawa A, Ezura M, Konno H, Suzuki M, Yoshimoto T. Brain single-photon emission CT studies using 99mTc-HMPAO and 99mTc-ECD early after recanalization by local intraarterial thrombolysis in patients with acute embolic middle cerebral artery occlusion. AJNR Am J Neuroradiol. 2001;22:48–53.

    PubMed  CAS  Google Scholar 

  46. Brinkmann BH, O’Brien TJ, Mullan BP, O’Connor MK, Robb RA, So EL. Subtraction ictal SPECT coregistered to MRI for seizure focus localization in partial epilepsy. Mayo Clin Proc. 2000;75:615–24.

    Article  PubMed  CAS  Google Scholar 

  47. Henry TR, Van Heertum RL. Positron emission tomography and single photon emission computed tomography in epilepsy care. Semin Nucl Med. 2003;33:88–8104.

    Article  PubMed  Google Scholar 

  48. Hong SB, Joo EY, Tae WS, Cho J-W, Lee J-H, Seo DW, et al. Preictal versus ictal injection of radiotracer for SPECT study in partial epilepsy: SISCOM. Seizure. 2008;17:383–6.

    Article  PubMed  Google Scholar 

  49. Kazemi NJ, Worrell GA, Stead SM, Brinkmann BH, Mullan BP, O’Brien TJ, et al. Ictal SPECT statistical parametric mapping in temporal lobe epilepsy surgery. Neurology. 2010;74:70–6.

    Article  PubMed  CAS  Google Scholar 

  50. Kim JH, Im KC, Kim JS, Lee S-A, Lee JK, Khang SK, et al. Ictal hyperperfusion patterns in relation to ictal scalp EEG patterns in patients with unilateral hippocampal sclerosis: a SPECT study. Epilepsia. 2007;48:270–7.

    Article  PubMed  Google Scholar 

  51. Turpin S, Lambert R, Dubois J, Diadori P. F-18 FDG brain PET and Tc-99m ECD brain SPECT in a patient with multiple recurrent epileptic seizures. Clin Nucl Med. 2010;35:123–5.

    Article  PubMed  Google Scholar 

  52. Van Paesschen W. Ictal SPECT. Epilepsia. 2004;45 Suppl 4:35–40. doi:10.1111/j.0013-9580.2004.04008.x.

    Article  PubMed  Google Scholar 

  53. Wichert-Ana L, de Azevedo-Marques PM, Oliveira LF, Fernandes RMF, Velasco TR, Santos AC, et al. Ictal technetium-99 m ethyl cysteinate dimer single-photon emission tomographic findings in epileptic patients with polymicrogyria syndromes: a subtraction of ictal-interictal SPECT coregistered to MRI study. Eur J Nucl Med Mol Imaging. 2008;35:1159–70.

    Article  PubMed  Google Scholar 

  54. Devanand DP, Van Heertum RL, Kegeles LS, Liu X, Jin ZH, Pradhaban G, et al. (99m)Tc hexamethyl-propylene-aminoxime single-photon emission computed tomography prediction of conversion from mild cognitive impairment to Alzheimer disease. Am J Geriatr Psychiatry. 2010;18:959–72.

    Article  PubMed  Google Scholar 

  55. Honda N, Machida K, Hosono M, Matsumoto T, Matsuda H, Oshima M, et al. Interobserver variation in diagnosis of dementia by brain perfusion SPECT. Radiat Med. 2002;20:281–9.

    PubMed  Google Scholar 

  56. Nobili F, Koulibaly M, Vitali P, Migneco O, Mariani G, Ebmeier K, et al. Brain perfusion follow-up in Alzheimer’s patients during treatment with acetylcholinesterase inhibitors. J Nucl Med. 2002;43:983–90.

    PubMed  CAS  Google Scholar 

  57. Roman G, Pascual B. Contribution of neuroimaging to the diagnosis of Alzheimer’s disease and vascular dementia. Arch Med Res. 2012;43:671–6.

    Article  PubMed  Google Scholar 

  58. Vasquez BP, Buck BH, Black SE, Leibovitch FS, Lobaugh NJ, Caldwell CB, et al. Visual attention deficits in Alzheimer’s disease: relationship to HMPAO SPECT cortical hypoperfusion. Neuropsychologia. 2011;49:1741–50.

    Article  PubMed  Google Scholar 

  59. Borghesani PR, DeMers SM, Manchanda V, Pruthi S, Lewis DH, Borson S. Neuroimaging in the clinical diagnosis of dementia: observations from a memory disorders clinic. J Am Geriatr Soc. 2010;58:1453–8.

    Article  PubMed  Google Scholar 

  60. Colloby SJ, Taylor JP, Firbank MJ, McKeith IG, Williams ED, O’Brien JT. Covariance 99mTc-exametazime SPECT patterns in Alzheimer’s disease and dementia with Lewy bodies: utility in differential diagnosis. J Geriatr Psychiatry Neurol. 2010;23:54–62.

    Article  PubMed  Google Scholar 

  61. Mitsumoto T, Ohya N, Ichimiya A, Sakaguchi Y, Kiyota A, Abe K, et al. Diagnostic performance of Tc-99m HMPAO SPECT for early and late onset Alzheimer’s disease: a clinical evaluation of linearization correction. Ann Nucl Med. 2009;23:487–95.

    Article  PubMed  Google Scholar 

  62. Paulino AC, Thorstad WL, Fox T. Role of fusion in radiotherapy treatment planning. Semin Nucl Med. 2003;33:238–43.

    Article  PubMed  Google Scholar 

  63. Grosu AL, Weber W, Feldmann HJ, Wuttke B, Bartenstein P, Gross MW, et al. First experience with I-123-alpha-methyl-tyrosine spect in the 3-D radiation treatment planning of brain gliomas. Int J Radiat Oncol Biol Phys. 2000;47:517–26.

    Article  PubMed  CAS  Google Scholar 

  64. Grosu AL, Feldmann H, Dick S, Dzewas B, Nieder C, Gumprecht H, et al. Implications of IMT-SPECT for postoperative radiotherapy planning in patients with gliomas. Int J Radiat Oncol Biol Phys. 2002;54:842–54.

    Article  PubMed  Google Scholar 

  65. Munley MT, Marks LB, Scarfone C, Sibley GS, Patz EF, Turkington TG, et al. Multimodality nuclear medicine imaging in three-dimensional radiation treatment planning for lung cancer: challenges and prospects. Lung Cancer. 1999;23:105–14.

    Article  PubMed  CAS  Google Scholar 

  66. Seppenwoolde Y, Engelsman M, De Jaeger K, Muller SH, Baas P, McShan DL, et al. Optimizing radiation treatment plans for lung cancer using lung perfusion information. Radiother Oncol. 2002;63:165–77.

    Article  PubMed  Google Scholar 

  67. Gemmel F, et al. Prosthetic joint infections: radionuclide state-of-the-art imaging. Eur J Nucl Med Mol Imaging. 2012;39(5):892–909.

    Article  PubMed  CAS  Google Scholar 

  68. Momose M, et al. Usefulness of 67Ga SPECT and integrated low-dose CT scanning (SPECT/CT) in the diagnosis of cardiac sarcoidosis. Ann Nucl Med. 2007;21(10):545–51.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine, Yale-New Haven Hospital-Saint Raphael Campus, Yale School of Medicine, New Haven, CT, USA

    Ali Gholamrezanezhad MD, FEBNM

Authors
  1. Ali Gholamrezanezhad MD, FEBNM
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ali Gholamrezanezhad MD, FEBNM .

Editor information

Editors and Affiliations

  1. Department of Nuclear Medicine, University Hospital Bonn, Bonn, Germany

    Hojjat Ahmadzadehfar

  2. Department of Nuclear Medicine, University Hospital Bonn, Bonn, Germany

    Hans-Jürgen Biersack

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Gholamrezanezhad, A. (2014). Miscellaneous: SPECT and SPECT/CT for Brain and Inflammation Imaging and Radiation Planning. In: Ahmadzadehfar, H., Biersack, HJ. (eds) Clinical Applications of SPECT-CT. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-35283-6_14

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-35283-6_14

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-35282-9

  • Online ISBN: 978-3-642-35283-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation